Inhibition of coxsackievirus B3 and related enteroviruses by antiviral short interfering RNA pools produced using φ6 RNA-dependent RNA polymerase

Journal of General Virology

Volumn 90, Issue 10, 2009, Pages 2468-2473

  Nygårdas, Michaela ^a   Vuorinen, Tytti ^a   Aalto, Antti P ^b   Bamford, Dennis H ^b   Hukkanen, Veijo ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; DOUBLE STRANDED RNA; RNA DIRECTED RNA POLYMERASE; SMALL INTERFERING RNA;

ARTICLE; BACTERIOPHAGE F1; COXSACKIE VIRUS A; COXSACKIE VIRUS A9; COXSACKIE VIRUS B3; COXSACKIE VIRUS B4; ENTEROVIRUS; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; BACTERIOPHAGE; CELL LINE; ENZYMOLOGY; METABOLISM; MOUSE; PHYSIOLOGY;

COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS B; PSEUDOMONAS PHAGE PHI-6;

ANIMALS; BACTERIOPHAGE PHI 6; CELL LINE; ENTEROVIRUS B, HUMAN; MICE; RNA INTERFERENCE; RNA REPLICASE; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 70350517279     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.011338-0     Document Type: Article

References (42)

1. Aalto, A. P., Sarin, L. P., van Dijk, A. A., Saarma, M. M., Poranen, M., Arumäe, U. & Bamford, D. H. (2007). Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage φ6 RNA-dependent RNA polymerase. RNA 13, 422-429.
2. Ahn, J., Jun, E., Lee, H., Yoon, S., Kim, D., Joo, C., Kim, Y. & Lee, H. (2005). A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge. J Virol 79, 8620-8624.
3. Bowles, N. E., Richardson, P. J., Olsen, E. G. & Archard, L. C. (1986). Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1, 1120-1123.
4. Buchholz, F., Kittler, R., Slabicki, M. & Theis, M. (2006). Enzymatically prepared RNAi libraries. Nat Methods 3, 696-700.
5. Carthew, R. W. & Sontheimer, E. J. (2009). Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655.
6. Castanotto, D. & Rossi, J. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426-433.
7. Fechner, H., Sipo, I., Westermann, D., Pinkert, S., Wang, X., Suckau, L., Kurreck, J., Zeichhardt, H., Müller, O. & other authors (2008). Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. J Mol Med 86, 987-997.
8. Gitlin, L., Karelsky, S. & Andino, R. (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418, 430-434.
9. Haasnoot, J., Westerhout, E. & Berkhout, B. (2007). RNA interference against viruses: strike and counterstrike. Nat Biotechnol 25, 1435-1443.
10. Harvala, H. (2003). Molecular pathogenesis of Coxsackievirus infections. The specific role of the RGD motif in CAV9. PhD dissertation. University of Turku, Turku, Finland. Annales Universitatis Turkuensis D564.
11. Hyöty, H. & Taylor, K. (2002). The role of viruses in human diabetes. Diabetologia 45, 1353-1361.
12. Judge, A. & MacLachlan, I. (2008). Overcoming the innate immune response to small interfering RNA. Hum Gene Ther 19, 111-124.
13. Kim, D. H., Longo, M., Han, Y., Lundberg, P., Cantin, E. & Rossi, J. J. (2004). Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22, 321-325.
14. Kim, Y. J., Ahn, J., Jeung, S. Y., Kim, D. S., Na, H. N., Cho, Y. J., Yun, S. H., Jee, Y., Jeon, E. S. & other authors (2008). Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model. Virus Genes 36, 141-146.
15. Klingel, K., McManus, B. & Kandolf, R. (1995). Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis? Eur Heart J 16 (Suppl. O), 42-45.
16. Krönke, J., Kittler, R., Buchholz, F., Windisch, M., Pietschmann, T., Bartenschlager, R. & Frese, M. (2004). Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol 78, 3436-3446.
17. Lee, H., Ahn, J., Jee, Y., Seo, I., Jeon, E., Jeon, E., Joo, C., Kim, Y. & Lee, H. (2007). Universal and mutation-resistant anti-enteroviral activity: potency of small interfering RNA complementary to the conserved cis-acting replication element within the enterovirus coding region. J Gen Virol 88, 2003-2012.
18. Leslie, K., Blay, R., Haisch, C., Lodge, A., Weller, A. & Huber, S. (1989). Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev 2, 191-203.
19. Lönnrot, M., Sjöroos, M., Salminen, K., Maaronen, M., Hyypiä, T. & Hyöty, H. (1999). Diagnosis of enterovirus and rhinovirus infections by RT-PCR and time-resolved fluorometry with lanthanide chelate labeled probes. J Med Virol 59, 378-384.
20. Löpez-Fraga, M., Wright, N. & Jiménez, A. (2008). RNA interference-based therapeutics: new strategies to fight infectious disease. Infect Disord Drug Targets 8, 262-273.
21. Lu, W. W., Hsu, Y. Y., Yang, J. Y. & Kung, S. H. (2004). Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem Biophys Res Commun 325, 494-499.
22. Makeyev, E. V. & Bamford, D. H. (2000a). Replicase activity of purified recombinant protein P2 of double-stranded RNA bacteriophage φ6. EMBO J 19, 124-133.
23. Makeyev, E. V. & Bamford, D. H. (2000b). The polymerase subunit of a dsRNA virus plays a central role in the regulation of viral RNA metabolism. EMBO J 19, 6275-6284.
24. Makeyev, E. V. & Bamford, D. H. (2001). Primer-independent RNA sequencing with bacteriophage φ6 RNA polymerase and chain terminators. RNA 7, 774-781.
25. McManus, B. M., Chow, L. H., Radio, S. J., Tracy, S. M., Beck, M. A., Chapman, N. M., Klingel, K. & Kandolf, R. (1991). Progress and challenges in the pathological diagnosis of myocarditis. Eur Heart J 12 (Suppl. D), 18-21.
26. Merl, S. & Wessely, R. (2007). Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides 17, 44-53.
27. Merl, S., Michaelis, C., Jaschke, B., Vorpahl, M., Seidl, S. & Wessely, R. (2005). Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 111, 1583-1592.
28. Mindich, L., Nemhauser, I., Gottlieb, P., Romantschuk, M., Carton, J., Frucht, S., Strassman, J., Bamford, D. & Kalkkinen, N. (1988). Nucleotide sequence of the large double-stranded RNA segment of bacteriophage φ6: genes specifying the viral replicase and transcriptase. J Virol 62, 1180-1185.
29. Rossi, J. J. (2009). Innate immunity confounds the clinical efficacy of small interfering RNAs (siRNAs). Gene Ther 16, 579-580.
30. Schubert, S., Grunert, H., Zeichhardt, H., Werk, D., Erdmann, V. & Kurreck, J. (2005). Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs. J Mol Biol 346, 457-465.
31. Schubert, S., Rothe, D., Werk, D., Grunert, H., Zeichhardt, H., Erdmann, V. & Kurreck, J. (2007). Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs. Antiviral Res 73, 197-205.
32. Sim, A. C., Luhur, A., Tan, T. M., Chow, V. T. & Poh, C. L. (2005). RNA interference against enterovirus 71 infection. Virology 341, 72-79.
33. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R. (2003). Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5, 834-839.
34. Tan, E. L., Tan, T. M., Chow, V. T. & Poh, C. L. (2007a). Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71. Antiviral Res 74, 9-15.
35. Tan, E. L., Tan, T. M., Tak Kwong Chow, V. & Poh, C. L. (2007b). Inhibition of enterovirus 71 in virus-infected mice by RNA interference. Mol Ther 15, 1931-1938.
36. Tan, E. L., Marcus, K. F. & Poh, C. L. (2008). Development of RNA interference (RNAi) as potential antiviral strategy against enterovirus 70. J Med Virol 80, 1025-1032.
37. Vidaver, A. K., Koski, R. K. & Van Etten, J. L. (1973). Bacteriophage φ6: a lipid-containing virus of Pseudomonas phaseolicola. J Virol 11, 799-805.
38. Vuorinen, T., Vainionpää, R., Heino, J. & Hyypiä, T. (1999). Enterovirus receptors and virus replication in human leukocytes. J Gen Virol 80, 921-927.
39. Werk, D., Schubert, S., Lindig, V., Grunert, H., Zeichhardt, H., Erdmann, V. & Kurreck, J. (2005). Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol Chem 386, 857-863.
40. Woodruff, J. F. (1980). Viral myocarditis. A review. Am J Pathol 101, 425-484.
41. Wu, Z., Gao, Y., Sun, L., Tien, P. & Jin, Q. (2008). Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16. Antiviral Res 80, 295-301.
42. Yuan, J., Cheung, P., Zhang, H., Chau, D. & Yang, D. (2005). Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J Virol 79, 2151-2159.